These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 12844134

  • 1. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.
    Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF.
    Clin Pharmacol Ther; 2003 Jul; 74(1):44-52. PubMed ID: 12844134
    [Abstract] [Full Text] [Related]

  • 2. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
    Liu J, Liu ZQ, Yu BN, Xu FH, Mo W, Zhou G, Liu YZ, Li Q, Zhou HH.
    Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
    [Abstract] [Full Text] [Related]

  • 3. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
    Liu J, Liu ZQ, Tan ZR, Chen XP, Wang LS, Zhou G, Zhou HH.
    Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
    Zineh I, Beitelshees AL, Gaedigk A, Walker JR, Pauly DF, Eberst K, Leeder JS, Phillips MS, Gelfand CA, Johnson JA.
    Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
    [Abstract] [Full Text] [Related]

  • 5. Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension.
    Beitelshees AL, Zineh I, Yarandi HN, Pauly DF, Johnson JA.
    Pharmacotherapy; 2006 Sep; 26(9):1247-54. PubMed ID: 16945046
    [Abstract] [Full Text] [Related]

  • 6. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG, Pauly DF, Lee CR, Patterson JH, Adams KF, Schofield RS, Belgado BS, Hamilton KK, Aranda JM, Hill JA, Yarandi HN, Walker JR, Phillips MS, Gelfand CA, Johnson JA.
    Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
    [Abstract] [Full Text] [Related]

  • 7. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
    Iaccarino G, Izzo R, Trimarco V, Cipolletta E, Lanni F, Sorriento D, Iovino GL, Rozza F, De Luca N, Priante O, Di Renzo G, Trimarco B.
    Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
    [Abstract] [Full Text] [Related]

  • 8. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.
    O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ.
    Clin Sci (Lond); 2000 Sep; 99(3):233-8. PubMed ID: 11787477
    [Abstract] [Full Text] [Related]

  • 9. Association of CYP2D6 and ADRB1 genes with hypotensive and antichronotropic action of betaxolol in patients with arterial hypertension.
    Zateyshchikov DA, Minushkina LO, Brovkin AN, Savel'eva EG, Zateyshchikova AA, Manchaeva BB, Nikitin AG, Sidorenko BA, Nosikov VV.
    Fundam Clin Pharmacol; 2007 Aug; 21(4):437-43. PubMed ID: 17635183
    [Abstract] [Full Text] [Related]

  • 10. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
    Schwartz SG, Puckett BJ, Allen RC, Castillo IG, Leffler CT.
    Ophthalmology; 2005 Dec; 112(12):2131-6. PubMed ID: 16325708
    [Abstract] [Full Text] [Related]

  • 11. Association of common polymorphisms in β1-adrenergic receptor with antihypertensive response to carvedilol.
    Si D, Wang J, Xu Y, Chen X, Zhang M, Zhou H.
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):306-9. PubMed ID: 25291495
    [Abstract] [Full Text] [Related]

  • 12. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT, Gong Y, Terra SG, Beitelshees AL, Langaee TY, Pauly DF, Schofield RS, Hamilton KK, Herbert Patterson J, Adams KF, Hill JA, Aranda JM, Johnson JA.
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [Abstract] [Full Text] [Related]

  • 13. Genetic polymorphisms of beta1 adrenergic receptor and their influence on the cardiovascular responses to metoprolol in a South Indian population.
    Mahesh Kumar KN, Ramu P, Rajan S, Shewade DG, Balachander J, Adithan C.
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):459-66. PubMed ID: 19033826
    [Abstract] [Full Text] [Related]

  • 14. Job strain, job demands and adrenergic beta1-receptor-polymorphism: a possible interaction affecting blood pressure in men.
    Ohlin B, Berglund G, Nilsson PM, Melander O.
    J Hypertens; 2008 Aug; 26(8):1583-9. PubMed ID: 18622236
    [Abstract] [Full Text] [Related]

  • 15. β(1)-adrenergic receptor polymorphisms and response to β-blockade in the African-American study of kidney disease and hypertension (AASK).
    Lee J, Aziz H, Liu L, Lipkowitz M, O'Connor DT, Richard E, Brophy V, Wassel CL, Blantz R, AASK Study Investigators, Bhatnagar V.
    Am J Hypertens; 2011 Jun; 24(6):694-700. PubMed ID: 21415838
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme gene I/D genotype affected metoprolol-induced reduction in 24-hour average heart rate.
    Liu LW, Liu H, Chen GL, Huang YL, Han LL, Xu ZM, Jiang XJ, Li YS.
    Chin Med J (Engl); 2010 Jun; 123(11):1382-6. PubMed ID: 20819590
    [Abstract] [Full Text] [Related]

  • 17. E112D polymorphism in the prolylcarboxypeptidase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients.
    Zhang Y, Hong XM, Xing HX, Li JP, Huo Y, Xu XP.
    Chin Med J (Engl); 2009 Oct 20; 122(20):2461-5. PubMed ID: 20079160
    [Abstract] [Full Text] [Related]

  • 18. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A, Clausell N, Santos KG, Salvaro R, Ashton-Prolla P, Borges A, Rohde LE.
    Am J Cardiol; 2008 Sep 15; 102(6):726-32. PubMed ID: 18773997
    [Abstract] [Full Text] [Related]

  • 19. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH, Hainer JW, Sugg J, M-FACT Study Group.
    Am J Hypertens; 2006 Apr 15; 19(4):388-95. PubMed ID: 16580575
    [Abstract] [Full Text] [Related]

  • 20. Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study.
    Fux R, Mörike K, Pröhmer AM, Delabar U, Schwab M, Schaeffeler E, Lorenz G, Gleiter CH, Eichelbaum M, Kivistö KT.
    Clin Pharmacol Ther; 2005 Oct 15; 78(4):378-87. PubMed ID: 16198657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.